PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹2,031 Cr | ₹1,095 Cr | ₹992 Cr | ₹1,034 Cr | ₹1,158 Cr |
What is the latest Net Current Assets ratio of PIRAMAL PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹2,031 Cr |
| Mar2024 | ₹1,095 Cr |
| Mar2023 | ₹992 Cr |
| Mar2022 | ₹1,034 Cr |
| Mar2021 | ₹1,158 Cr |
How is Net Current Assets of PIRAMAL PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,031 Cr | 85.43 | |
| Mar2024 | ₹1,095 Cr | 10.35 | |
| Mar2023 | ₹992 Cr | -4.01 | |
| Mar2022 | ₹1,034 Cr | -10.75 | |
| Mar2021 | ₹1,158 Cr | - | |
Compare Net Current Assets of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,121.1 Cr | -5.1% | -10% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -5.1% |
-10% |
-20% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses